Hematology Flashcards

1
Q

Venipuncture order of draw

A

Yellow (SPS, blood culture tubes)
Light Blue (sodium citrate)
Red (serum with or without gel separator)
Green (heparin)
Lavender (EDTA)
Gray (sodium fluoride or oxalate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Skin puncture order of draw

A

Tube for blood gas analysis
Slides
EDTA microcollection tube
Other microcollection tubes
Serum microcollection tubes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Tourniquet is wrapped around the arm about _____ above the selected site

A

3-4 inches (7.5-10 cm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Tourniquet should not remain on the arm for longer than

A

1 min (or 2 mins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Length of needle used in phlebotomy

A

1 (to 1.5) inch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Needle angle for venipuncture

A

15 (to 30) degrees, bevel up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Most common needle size and length for adult venipuncture

A

Gauge 21, 1 inch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Needle gauge for PEDIATRIC phlebotomy

A

Gauge 23 (or 22)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Needle gauge for bleeding donors

A

Gauge 16

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Needle gauge for TUBERCULIN syringe

A

Gauge 25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Needle gauge for TRANSFER of blood from syringe to tube

A

Gauge 19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Size of BLOOD DROP for smear preparation

A

2-3 mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Distance of blood drop from the frosted edge of the slide

A

1 cm (0.25 inch)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Distance where smears terminates near the end of slide (automated spreader)

A

0.5 inch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Angle between 2 slides when making blood smear

A

30-45 degrees

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Slide angle for blood smear preparation if patient has POLYCYTHEMIA

A

25 degrees (decrease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Size of square coverslip

A

22 x 22 mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Wintrobe tube length

A

115 mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Wintrobe tube bore

A

3 mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Wintrobe tube is graduated at

A

0-100 mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Length of capillary tube

A

7.0-7.5 cm (70-75mm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Bore of capillary tube

A

1.0 (or 1.2) mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Thickness pf clayseal in microhematocrit tube

A

4-6 mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Centrifugation speed and time for microhematocrit method

A

10,000-15,000g for 5 mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Microhematocrit tubes should be read within how many minutes

A

10 minutes after centrifugation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Trapped plasma increases hematocrit reading by how much

A

1-3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Coefficient of variation for most hematology tests should be

A

<5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Marks seen on a Thoma WBC pipet

A

0.5, 1, 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Marks seen on a Thoma RBC pipet

A

0.5, 1, 101

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Total are of the Levy chamber

A

9mm^2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Patient has a normal RBC count. How many RBCs will be seen per OIF

A

200-250

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Dilution for RBC count using automated counting instrument

A

1:50,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Factor used when performing WBC estimate using OIO

A

3,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Factor used when performing WBC estimate using HPO

A

2,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

After charging, allow WBCs to settle in hemocytometer for ___ minutes

A

5 (or 10) minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Most commonly used dilution for WBC count

A

1:20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Dilution used when WBC count is <3.0 x 10^9/L

A

1:10 (or 1:11)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Dilution used when WBC count is >30.0 x 10^9/L

A

1:100 (or 1:101)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Dilution used when WBC count is between 100-300 x 10^9/L

A

1:200 (or 1:201)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

WBC count is <1.0 x 10^9/L, how many WBCs are counted in the differential

A

50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

WBC count is >40 x 10^9/L, how many WBCs are counted in the differential

A

200

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

WBC count is 100 x 10^9/L, how many WBCs are counted in the differential

A

300-400

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

WBC count should be corrected when there are how many nRBCs present

A

5 (or 10)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Life span of RBC

A

120 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Average diameter of RBCs

A

6-8 um (or 7.2 um)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Size of microcytic RBCs

A

<6 um

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

How many hours does a neutrophil stay in the peripheral blood

A

7 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Life span of neutrophils

A

5 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Maturation time of eosinophils

A

3.5 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Half-life of eosinophil in the blood

A

8 (or 18) hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Maturation time of basophils

A

7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Average diameter of platelets

A

2.5 um

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Standard dilution for platelet count

A

1:100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Dilution if <50 platelets are counted on each side of hemacytometer

A

1:20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Dilution if >500 platelets are counted on each side of hemacytometer

A

1:200

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

After charging, allow platelets to settle in hemocytometer for ___ minutes

A

15 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Area of square used for counting platelets using ammonium oxalate

A

1 mm^2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Number of platelets per OIF when doing platelet estimate

A

8-20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Factor used when doing a platelet estimate in the peripheral blood smear

A

20,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Normal value for MPV

A

7.0 to 12.0 fL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Normal value for PDW

A

<20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Normal template bleeding time

A

6-10 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

In DIC, D-dimer test will be positive after how many hours

A

4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Specimens for PT and APTT must be centrifuged within

A

1 hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Reference range for PTT

A

25 - 35 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Reference range for PT

A

12.6 - 14.6 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Reference range for thrombin time

A

21 seconds or less than

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

INR for DEEP VEIN THROMBOSIS and myocardial infarction

A

2.0 to 3.0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

INR for patients with PROSTHETIC HEART VALVES

A

2.5 to 3.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

INR for patients with PULMONARY EMBOLISM

A

3.0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Peripheral blood smear should be __________ the length of the slide

A

2/3 to 3/4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

The shape of blood smear should be

A

Finger-shaped

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Pressure in THICK smear should be

A

Decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Pressure in THIN smear should be

A

Increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Angle, size of blood, speed of spreader in the THICK smear should be

A

Increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Angle, size of blood, speed of spreader in the THIN smear should be

A

Decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Too pale or red RBCs and barely visible WBCs is caused by

A

Too acidic buffer or stain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Gray RBCs and too dark WBCs is caused by

A

Too alkaline buffer or stain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Holes in the smear means that

A

There is a dirt or grease on the slide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

“Snowplow” effect on a blood smear must be examined using what objective

A

LPO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Tube layers of spun hematocrit

A

Fatty layer (top)
Plasma (2nd layer)
Buffy coat (3rd layer)
Packed RBCs (4th layer)
Clay (5th layer)
Wax (6th layer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Cell cycle phase: Resting phase

A

Gap 0 (G0)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Cell cycle phase: Ready for DNA SYNTHESIS

A

Gap 1 (G1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Cell cycle phase: DNA REPLICATION

A

Synthesis (S)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Cell cycle phase: Ready for CELL DIVISION

A

Gap 2 (G2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

Cell cycle phase: Ready to COMPLETE DIVISION

A

Mitosis (M)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Duration of Synthesis

A

8 (or 7.5) hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Duration of Gap 2

A

4 (or 3.5) hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

KIT ligand, FLT3 ligand, GM-CSF, INTERLEUKINS 1, 3, 6, 11 has (positive/negative) influence on HSC stem cells and progenitors

A

Positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Transforming growth factor-B, TNF-a, INTERFERONS has (positive/negative) influence on HSC stem cells and progenitors

A

Negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

Erythroid with a “WHEEL SPOKE” pattern of chromatin

A

Basophilic normoblast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

Cell with a nucleus having “CHECKERBOARD” appearance

A

Polychromatic normoblast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

Most reliable criterion to differentiate mature from immature cell

A

Nuclear chromatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

Embryonic Hemoglobins

A

Gower I
Gower II
Portland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Normal hemoglobins

A

HbF
HbA
HbA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

Abnormal hemoglobins

A

Bart
HbH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

2 zeta, 2 epsilon

A

Gower I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

2 alpha 2 epsilon

A

Gower II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

2 zeta 2 gamma

A

Portland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

2 alpha 2 GAMMA

A

HbF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

2 alpha 2 BETA

A

HbA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

2 alpha 2 DELTA

A

HbA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

4 gamma

A

Bart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

4 beta

A

HbH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

Hemoglobin solubility test / Dithionite test is a screening test for

A

Hemoglobin S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

Dithionite test reagents

A

Sodium hydrosulfite (dithionite), saponin, filter paper

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Dithionite test principle

A

Reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

Positive result for dithionite test

A

Solution becomes turbid (black lines cannot be seen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

Negative result for dithionite test

A

Solution remains clear (black lines are visible)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

Conditions with INCREASED ESR

A

*Macro HAM High VREeD

Macrocytosis
Hyperfibrinogenemia
Anemia
Multiple myeloma
High room temperature
Vibration
Refrigerated sample (not returned to room temp)
DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

Spur/thorn cell

A

Acanthocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

Punched-out cell

A

Anulocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

Target/mexican hat cell/leptocyte

A

Codocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

Teardrop/pear-shaped cell

A

Dacryocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

Bite cell

A

Degmacyte

116
Q

Sickle cell/menisocyte

A

Drepanocyte

117
Q

Burr cell/sea urchin/crenated cell

A

Echinocyte

118
Q

Rod/cigar-shaped cell

A

Elliptocyte

119
Q

Helmet cell

A

Keratocyte

120
Q

Ball/bronze cell

A

Spherocyte

121
Q

Mouth cell

A

Stomatocyte

122
Q

Half moon/crescent cell

A

Semi-lunar bodies

123
Q

Neutrophil granules formed during PROMYELOCYTE stage

A

Primary (azurophilic)

124
Q

Neutrophil granules formed during MYELOCYTE stage

A

Secondary (specific)

125
Q

Neutrophil granules formed during METAMYELOCYTE and BAND stages

A

Tertiary

126
Q

MYELOPEROXIDASE is seen in what neutrophil granules

A

Primary (azurophilic)

127
Q

LYSOZYME is seen in what neutrophil granules

A

Tertiary

128
Q

Primary granules of EOSINOPHILS consists of

A

Charcot-Leyden crystal protein

129
Q

Catalase and elastase are seen in what eosinophil granules

A

Small lysosomal granules

130
Q

CYCLOOXIGENASE is seen in what type of eosinophil granules

A

Lipid bodies

131
Q

Eosinophil granules that CARRIES PROTEIN from secondary granules to be released into the extracellular medium

A

Storage vesicles

132
Q

Basophil granules that carries histamine, platelet-activating factor, vascular endothelial growth factor and chondroitin sulfates

A

Secondary granules

133
Q

Not an obligate end cell

A

Lymphocyte

134
Q

Most fragile blood cell

A

Lymphocyte

135
Q

DECREASED NUCLEAR SEGMENTATION in neutrophils

A

Pelger-Huet anomaly

136
Q

GIANT LYSOSOMAL GRANULES in granulocytes, monocytes, and lymphocytes

A

Chediak-Higashi disease

137
Q

Thrombocytopenia, GIANT PLATELETS, pale blue inclusion and LARGE Dohle body-like inclusions in WBCs

A

May-Hegglin anomaly

138
Q

Presence of PHILADELPHIA CHROMOSOME

A

CML (chronic myelogenous leukemia)

139
Q

INCREASED LAP (leukocyte alkaline phosphatase) is seen in what condition

A

PV (polycythemia vera)

140
Q

DECREASED LAP (leukocyte alkaline phosphatase) is seen in what condition

A

CML (chronic myelogenous leukemia)

141
Q

Transforms into ACUTE LEUKEMIA

A

CML (chronic myelogenous leukemia)

142
Q

Acute UNDIFFERENTIATED leukemia

A

M0

143
Q

Acute myeloblastic leukemia (AML) WITHOUT maturation

A

M1

144
Q

Acute myeloblastic leukemia (AML) WITH maturation

A

M2

145
Q

Acute promyelocytic leukemia (APL)

A

M3

146
Q

APL associated with DIC and numerous FAGGOT CELLS

A

M3

147
Q

Acute myelomonocytic leukemia (AMML) also known as Naegeli’s leukemia

A

M4

148
Q

Acute monoblastic leukemia (AMoL) WITHOUT maturation

A

M5a

149
Q

Acute monoblastic leukemia (AMoL) WITH maturation

A

M5b

150
Q

Erythroleukemia / Di Guglielmo’s syndrome

A

M6

151
Q

Acute megakaryoblastic leukemia (AMegL)

A

M7

152
Q

Acute basophilic leukemia

A

M8

153
Q

Acute lymphoblastic leukemia (ALL) with SMALL, HOMOGENOUS cell and SCANTY cytoplasm

A

L1

154
Q

Acute lymphoblastic leukemia (ALL) with LARGE, HETEROGENOUS cell and LARGE nucleoli

A

L2

155
Q

Acute lymphoblastic leukemia (ALL) with LARGE, HOMOGENOUS cell and PROMINENT cytoplasmic vacuolation

A

L3 / Burkitt Type

156
Q

Cottage loaf nucleus

A

M3

157
Q

Both myeloid and monocytic cells are present; at least 20% of the total leukocytes

A

M4

158
Q

Erythroid and granulocytic precursors; megakaryocytic and monocytic proliferations

A

M6

159
Q

UNDIFFERENTIATED leukemia

A

Stem cell leukemia

160
Q

POORLY differentiated leukemia

A

Acute lymphoblastic leukemia

161
Q

WELL differentiated leukemia

A

Chronic lymphocytic leukemia

162
Q

Solid tumor counterpart of myeloma

A

Plasma cell leukemia

163
Q

PPE for enteric isolation

A

Gloves and gown

164
Q

PPE for protective isolation

A

Gown, gloves, mask

165
Q

An example of conditions that requires protective isolation

A

Leukemia

166
Q

Sheep RBC receptor, (+) E rosette assay

A

CD2

167
Q

Helper T cell

A

CD4

168
Q

Also known as CALLA (common acute lymphocytic leukemia antigen)

A

CD10

169
Q

NK cells marker

A

CD 16, CD 56

170
Q

Hematopoietic stem cells marker

A

CD34

171
Q

Platelet structure that consists of surface coat (glycocalyx) and is responsible for ADHESION and AGGREGATION

A

Peripheral zone

172
Q

Platelet structure that MAINTAINS THE POSITION of the organelles

A

Sol-Gel Zone

173
Q

Sol-Gel Zone that is composed of ACTIN AND MYOSIN to form actomyosin / thrombosthenin

A

Microfilaments

174
Q

Sol-Gel Zone that is composed of TUBULIN which maintains platelet’s discoid SHAPE

A

Microtubules

175
Q

A contractile protein important in CLOT RETRACTION

A

Thrombosthenin

176
Q

Platelet structure that is composed of dense granules, alpha-granules, lysosomes and mitochondria

A

Organelle zone

177
Q

Megakaryocytic differentiation stage with INDENTED nucleus

A

MK-II (promegakaryocyte)

178
Q

Megakaryocytic differentiation stage with MULTILOBED nucleus

A

MK-III (megakaryocyte)

179
Q

Megakaryocytic differentiation stage with a VARIABLE nucleoli

A

MK-II (promegakaryocyte)

180
Q

Megakaryocytic differentiation stage with MODERATELY condensed chromatin

A

MK-II (promegakaryocyte)

181
Q

Megakaryocytic differentiation stage with DEEPLY but VARIABLY condensed chromatin

A

MK-III

182
Q

Megakaryocytic differentiation stage where ENDOMITOSIS ENDS

A

MK II (promegakaryocyte)

183
Q

Megakaryocytic differentiation stage where there is NO ENDOMITOSIS

A

MK-III (megakaryocyte)

184
Q

Megakaryocytic differentiation stage that has an EOSINOPHILIC and GRANULAR cytoplasm

A

MK-III (megakaryocyte)

185
Q

Present in ALL megakaryocytic differentiation stages (MK-I, MK-II, MK-III)

A

Alpha and dense granules, demarcation system

186
Q

Associated with endomitosis

A

Thrombocytes

187
Q

Acquired platelet dysfunctions

A

*LUPA

Liver disease
Uremia
Pernicious anemia
Aspirin (drugs)

188
Q

Hereditary platelet dysfunctions

A

von Willebrand disease
Bernard-Soulier syndrome
Thrombasthenia (Glanzmann’s, essential)

189
Q

Factor I

A

Fibrinogen

190
Q

Factor II

A

Prothrombin

191
Q

Factor III

A

Tissue factor

192
Q

Factor IV

A

Calcium

193
Q

Factor V

A

Labile factor / Proaccelerin

194
Q

Factor VII

A

Stable factor / Proconvertin

195
Q

Factor VIII

A

Anti-hemophilic factor A

196
Q

Factor IX

A

PTC (plasma thromboplastin component) / Anti-hemophilic factor B / Christmas factor

197
Q

Factor X

A

Stuart factor

198
Q

Factor XI

A

PTA (plasma thromboplastin antecedent) / Anti-hemophilic factor C

199
Q

Factor XII

A

Hageman factor / Contact factor

200
Q

Factor XIII

A

Fibrin stabilizing factor / Laki-Lorand factor

201
Q

PK

A

Prekallikrein / Fletcher factor

202
Q

HMWK

A

Fitzgerald factor

203
Q

Prothrombin (PT) group

A

II, VII, IX, X

204
Q

Fibrinogen group

A

I, V, VIII, XIII

205
Q

Contact group

A

XI, XII, PK, HMWK

206
Q

Calcium dependent, Vitamin K DEPENDENT *dede

A

Prothrombin group (II, VII, IX, X)

207
Q

Calcium INdependent, vitamin K INdependent

A

Contact group (XI, XII, PK, HMWK)

208
Q

Calcium dependent, vitamin K INDEPENDENT

A

Fibrinogen group (I, V, VIII, XIII)

209
Q

Completely consumed during coagulation

A

Fibrinogen group (I, V, VIII, XIII)

210
Q

First coagulation factor affected by COUMARIN

A

Factor VII
(VII ➡️ IX ➡️ X ➡️ 2)

211
Q

Factor VIII:C

A

Factor VIII procoagulant activity

212
Q

Initial vWD workup

A

CBC, PT, APTT

213
Q

Deficiencies of factors II, V, VII, X ; prolonged clotting time. What test

A

Prothrombin time (PT)

214
Q

Deficiencies of ALL factors EXCEPT VII, XIII ; prolonged clotting time. What test

A

Partial thromboplastin time (PTT)

215
Q

PT reagent composition

A

Thromboplastin + phospholipids + calcium chloride

216
Q

APTT reagent composition

A

Activator + phospholipid

217
Q

How many uL of PT reagent

A

200 uL

218
Q

PROLONGED (PT), PROLONGED (APTT) , PROLONGED (CT)

A

Fibrinogen

219
Q

PROLONGED (PT), PROLONGED (APTT) , NORMAL (CT)

A

II, V, X

220
Q

PROLONGED (PT), NORMAL (APTT) , NORMAL (CT)

A

VII

221
Q

NORMAL (PT), PROLONGED (APTT) , NORMAL (CT)

A

VIII, IX, XI

222
Q

NORMAL (PT), NORMAL (APTT) , NORMAL (CT)

A

XIII

223
Q

Platelet size threshold

A

2-20 fL

224
Q

High-angle forward scatter, 5-15 degrees

A

Technicon Angle 2

225
Q

Instrument POSITIVE errors

A

Bubbles in the sample
Electrical pulses
Aperture plugs

226
Q

Instrument NEGATIVE error

A

Excessive lysing of RBCs

227
Q

Giant platelets may be counted as

A

RBC or WBC

228
Q

Increased number of _____ makes accurate RBC and platelet count imposible

A

Schistocytes

229
Q

Agglutinated __________ may cause false-POSITIVE LEUKOCYTE counts

A

RBCs or platelets

230
Q

When 2 cells pass through an orifice simultaneously and counted as 1 cell, it is called

A

Coincidence

231
Q

Semi-automated coagulation instrument

A

Fibrometer
KC4 Delta
STart4

232
Q

Automated coagulation instrument

A

MDA, AMAX, STA-R, BCR, ACL

233
Q

Endpoint in electromechanical clot detection systems

A

Clot formation via clotting time

234
Q

Parameter affected by cold agglutinins

A

Decrease RBC, Increased MCV and MCHC

235
Q

Corrective action for cold agglutinins

A

Warm specimen to 37C and rerun

236
Q

Parameters affected if specimen is lipemic / icteric

A

Increase hemoglobin and MCH

237
Q

Parameters affected if specimen is hemolyzed

A

Decrease RBC and hematocrit

238
Q

Parameters affected in the presence of microcytes / schistocytes

A

Increase platelets, decrease RBC

239
Q

Parameters affected in the presence of nucleated RBCs and megakaryocyte

A

Increase WBCs

240
Q

Parameters affected if there is a presence of platelet clumps

A

Decrease platelets, increase WBC

241
Q

What is the corrective action for platelet clumps

A

Redraw specimen in SODIUM CITRATE, multiply result by 1.1

242
Q

Aggregates of 3-4 RBCs. What rouleaux grading

A

1+

243
Q

Aggregates of 5-10 RBCs. What rouleaux grading

A

2+

244
Q

Numerous aggregates with few free RBCs. What grading

A

3+

245
Q

1-2 RBC chains PER FIELD. What rouleaux grading

A

Slight

246
Q

3-4 RBC chains PER FIELD. What rouleaux grading

A

Moderate

247
Q

5 or more RBC chains PER FIELD. What rouleaux grading

A

Marked

248
Q

Polychromasia grading of 1%

A

Slight

249
Q

Polychromasia grading of 3%

A

1+

250
Q

Polychromasia grading of 5%

A

2+

251
Q

Polychromasia grading of 10%

A

3+

252
Q

Polychromasia grading of >11%

A

4+

253
Q

Macrocytosis grading of 25%

A

1+ (slight)

254
Q

Macrocytosis grading of 25-50%

A

2+ to 3+ (moderate)

255
Q

Macrocytosis grading of >50%

A

4+ (marked)

256
Q

1/3 of the cell diameter. What hypochromia grading

A

Normal

257
Q

1/2 of the cell diameter. What hypochromia grading

A

1+

258
Q

2/3 of the cell diameter. What hypochromia grading

A

2+

259
Q

3/4 of the cell diameter. What hypochromia grading

A

3+

260
Q

Thin rim of hemoglobin / ANULOCYTE. What hypochromia grading

A

4+

261
Q

> 2/3 of the cell diameter. What hypochromia grading

A

2+ to 3+ (moderate)

262
Q

150,000 - 199,000 / uL platelet estimate

A

Low normal

263
Q

100,000 - 149,000 / uL platelet estimate

A

Slight decrease

264
Q

50,000 - 99,000 / uL platelet estimate

A

Moderate decrease

265
Q

0 - 49,000 / uL platelet estimate

A

Marked decrease

266
Q

200,000 - 400,000 / uL platelet estimate

A

Normal

267
Q

401,000 - 599,000 / uL platelet estimate

A

Slight decrease

268
Q

600,000 - 800,000 / uL platelet estimate

A

Moderate increase

269
Q

> 800,000 / uL platelet estimate

A

Marked increase

270
Q

“Normal / slight” what erythrocyte grading

A

0

271
Q

“Small / few” what erythrocyte grading

A

1+

272
Q

“Moderately” what erythrocyte grading

A

2+

273
Q

“Many” what erythrocyte grading

A

3+

274
Q

“Marked” what erythrocyte grading

A

4+

275
Q

0-2 / OIF codocytes, ovalocytes, stomatocytes

A

Within normal limits

276
Q

2-10/ OIF codocytes, ovalocytes, stomatocytes

A

1+

277
Q

10-20 / OIF codocytes, ovalocytes, stomatocytes

A

2+

278
Q

20-50 / OIF codocytes, ovalocytes, stomatocytes

A

3+

279
Q

> 50/ OIF codocytes, ovalocytes, stomatocytes

A

4+

280
Q

<1 / OIF acanthocytes, schisocytes

A

Within normal limits

281
Q

2-5 / OIF acanthocytes, schisocytes

A

1+

282
Q

5-10 / OIF acanthocytes, schisocytes

A

2+

283
Q

10-20 / OIF acanthocytes, schisocytes

A

3+

284
Q

> 20 / OIF acanthocytes, schisocytes

A

4+

285
Q

1+ (1-5/field), 2+ (6-10/field), 3+ (>10/field). These are reportings for

A

Spherocytes, Acanthocytes, Schistocytes

286
Q

1+ (3-10/field), 2+ (11-20/field), 3+ (>20field). These are reportings for

A

Codocytes, Ovalocytes, Stomatocytes

287
Q

Sickle cells, BASOPHILIC STIPPLING, Pappenheimer and Howell-Jolly bodies are reported as

A

Positive